---
figid: PMC3114474__JBB2011-165214.001
figlink: /pmc/articles/PMC3114474/figure/fig1/
number: F1
caption: Mechanism of acquired resistance to EGFR-TKI (modified from reviews of Mitsudomi
  and Yataba [] and Yano []). (a) Survival signal through the PI3K/Akt pathway in
  NSCLC cells with an EGFR activating mutation (star). (b) EGFR-TKI inhibits phosphorylation
  of EGFR and the survival signal is shut down, leading to apoptosis of cells. (c)
  Secondary T790M mutation prevents binding of EGFR-TKI to EGFR, resulting in cell
  survival. (d) Amplified MET causes phosphorylation of ERBB3. Even when phosphorylation
  of EGFR is inhibited by EGFR-TKI, activation of the PI3K/Akt pathway is maintained
  through ERBB3. (e) HGF induces activation of the PI3K/Akt pathway through MET; this
  activation is independent of ERBB3 or EGFR.
pmcid: PMC3114474
papertitle: Mechanisms of Resistance to EGFR TKIs and Development of a New Generation
  of Drugs in Non-Small-Cell Lung Cancer.
reftext: Takayuki Kosaka, et al. J Biomed Biotechnol. 2011;2011:165214.
pmc_ranked_result_index: '110755'
pathway_score: 0.9458211
filename: JBB2011-165214.001.jpg
figtitle: Mechanisms of Resistance to EGFR TKIs and Development of a New Generation
  of Drugs in Non-Small-Cell Lung Cancer.
year: '2011'
organisms:
- Homo sapiens
ndex: c86ee192-de93-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3114474__JBB2011-165214.001.html
  '@type': Dataset
  description: Mechanism of acquired resistance to EGFR-TKI (modified from reviews
    of Mitsudomi and Yataba [] and Yano []). (a) Survival signal through the PI3K/Akt
    pathway in NSCLC cells with an EGFR activating mutation (star). (b) EGFR-TKI inhibits
    phosphorylation of EGFR and the survival signal is shut down, leading to apoptosis
    of cells. (c) Secondary T790M mutation prevents binding of EGFR-TKI to EGFR, resulting
    in cell survival. (d) Amplified MET causes phosphorylation of ERBB3. Even when
    phosphorylation of EGFR is inhibited by EGFR-TKI, activation of the PI3K/Akt pathway
    is maintained through ERBB3. (e) HGF induces activation of the PI3K/Akt pathway
    through MET; this activation is independent of ERBB3 or EGFR.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3R3
  - ERBB3
  - EGFR
  - PIK3CG
  - PIK3CA
  - PIK3R4
  - HGF
  - AKT2
  - PIK3CD
  - PIK3R5
  - MET
  - AKT1
  - PIK3CB
  - AKT3
  - PIK3R6
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: ERBB3
  symbol: ERBB3
  source: hgnc_symbol
  hgnc_symbol: ERBB3
  entrez: '2065'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: HGF
  symbol: HGF
  source: hgnc_symbol
  hgnc_symbol: HGF
  entrez: '3082'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: MET
  symbol: MET
  source: hgnc_symbol
  hgnc_symbol: MET
  entrez: '4233'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
chemicals: []
diseases: []
figid_alias: PMC3114474__F1
redirect_from: /figures/PMC3114474__F1
figtype: Figure
---
